{"id":265866,"date":"2018-01-22T11:30:22","date_gmt":"2018-01-22T16:30:22","guid":{"rendered":"https:\/\/policyoptions.irpp.org\/issues\/good-governance-and-decision-making-on-drug-coverage\/"},"modified":"2025-10-07T21:56:41","modified_gmt":"2025-10-08T01:56:41","slug":"good-governance-and-decision-making-on-drug-coverage","status":"publish","type":"issues","link":"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/","title":{"rendered":"Good governance and decision-making on drug coverage"},"content":{"rendered":"<p class=\"dropcap-big\">The federal Minister of Health has initiated an external\u00a0<a href=\"https:\/\/www.canada.ca\/en\/health-canada\/programs\/external-advisory-body-pan-canadian-health-organizations\/external-review-stakeholder-guidelines-questions.html?utm_source=%2ALIVE%2A+CADTH%2FACMTS+Confirmed+Subscribers&amp;utm_campaign=030ead40b7-E_Alert_PCHO-11_03_2017&amp;utm_medium=email&amp;utm_term=0_2e3705996c-030ead40b7-262962993\">review<\/a>\u00a0of eight pan-Canadian health organizations. One of these is\u00a0the\u00a0Canadian Agency for Drugs and Technologies in Health (CADTH), which evaluates\u00a0and recommends\u00a0new drugs for insurance coverage within all federal, provincial and territorial public drug plans, except those in Quebec. CADTH\u00a0<a href=\"https:\/\/www.cadth.ca\/about-cadth\/who-we-are\">describes<\/a>\u00a0itself as \u201can independent, not-for-profit organization responsible for providing Canada\u2019s health\u00a0care decision-makers with objective evidence to help make informed decisions about the optimal use of drugs.\u201d\u00a0These decisions frequently lead to Canadians being denied\u00a0access\u00a0to\u00a0potentially life-saving or life-transforming\u00a0innovative medicines.\u00a0<span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p>Why?\u00a0One reason, we argue,\u00a0is that\u00a0CADTH\u2019s drug review processes do not adhere to good\u00a0governance\u00a0principles, as we explored in a\u00a0<a href=\"https:\/\/www.dovepress.com\/articles.php?article_id=35696\">recent article<\/a>\u00a0in the peer-reviewed journal\u00a0<i>ClinicoEconomics\u00a0and Outcomes Research<\/i>. Governance is something\u00a0few\u00a0Canadians think\u00a0much\u00a0about.\u00a0But\u00a0decisions made using\u00a0processes that fail to follow good governance principles can negatively\u00a0impact\u00a0Canadians\u2019\u00a0lives.\u00a0<span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">CADTH has separate processes for\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">the\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">review of cancer drugs and all other drugs<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">;<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">i<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">ts<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">\u00a0reviews of\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">noncancer\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">medications<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">result<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">in<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">\u00a0only about half\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">of\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">the<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">se<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">\u00a0drugs\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">being recommended for coverage<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">by public plans<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">.<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">The\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">outcome<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">\u00a0is that<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">patients\u2019 access is\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">delayed or denied<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">\u00a0to new drugs<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">, including\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">drugs\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">for diseases that have no other treatments<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">,<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">\u00a0such as\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"SpellingError SCXW133892642\">Orkambi<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">\u00a0for cystic fibrosis<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">.\u00a0<\/span><span class=\"SpellingError SCXW133892642\">Orkambi<\/span><span class=\"NormalTextRun SCXW133892642\">\u00a0received a priority regulatory review\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">(<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">meaning Health Canada considered that the drug filled an unmet need<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">)<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">,\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">but\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">CADTH recommend<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">ed<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">\u00a0that public drug plans\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">not\u00a0<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">cover it<\/span><\/span><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">, denying\u00a0<\/span><span class=\"SpellingError SCXW133892642\">Orkambi\u2019s<\/span><span class=\"NormalTextRun SCXW133892642\">\u00a0<\/span><\/span><a class=\"Hyperlink SCXW133892642\" href=\"https:\/\/vancouversun.com\/news\/local-news\/uvic-student-pins-drug-hopes-on-price-battle\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"TextRun Underlined SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">benefits<\/span><\/span><\/a><span class=\"TextRun SCXW133892642\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW133892642\">\u00a0to several hundred cystic fibrosis sufferers.<\/span><\/span><span class=\"EOP SCXW133892642\" data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p class=\"dropcap\"><span class=\"TextRun Highlight SCXW101730496\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW101730496\">W<\/span><\/span><span class=\"TextRun SCXW101730496\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW101730496\">hat are good governance principles? The<\/span><\/span><span class=\"TextRun SCXW101730496\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW101730496\">se are the<\/span><\/span><span class=\"TextRun SCXW101730496\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW101730496\">\u00a0main ones\u00a0<\/span><\/span><span class=\"TextRun SCXW101730496\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW101730496\">relating to\u00a0<\/span><\/span><span class=\"TextRun SCXW101730496\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW101730496\">drug reimbursement recommendation<\/span><\/span><span class=\"TextRun SCXW101730496\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW101730496\">s<\/span><\/span><span class=\"TextRun SCXW101730496\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW101730496\">:<\/span><\/span><span class=\"EOP SCXW101730496\" data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"24\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">accountability:\u00a0decision-makers\u00a0should be\u00a0accountable to\u00a0everyone\u00a0impacted by their\u00a0decision,\u00a0<span data-ccp-props=\"{&quot;134233279&quot;:true}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"24\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">transparency:\u00a0processes and information\u00a0should be\u00a0directly accessible to\u00a0all\u00a0concerned and enough information provided to understand and monitor them,\u00a0<span data-ccp-props=\"{&quot;134233279&quot;:true}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"24\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">equity:\u00a0all involved\u00a0should have\u00a0opportunities to improve or maintain their well-being,\u00a0<span data-ccp-props=\"{&quot;134233279&quot;:true}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"24\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">participation:\u00a0everyone impacted by the decision\u00a0should have a voice in decision-making directly or through legitimate representatives,\u00a0<span data-ccp-props=\"{&quot;134233279&quot;:true}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"24\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\">consensus:\u00a0differing interests\u00a0should be\u00a0reconciled to reach broad\u00a0agreement\u00a0on what is in the best interest of\u00a0all\u00a0participants\u00a0and\u00a0<span data-ccp-props=\"{&quot;134233279&quot;:true}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"24\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\">responsiveness:\u00a0organizations and processes\u00a0should\u00a0serve\u00a0all\u00a0involved.<span data-ccp-props=\"{&quot;134233279&quot;:true}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">How do\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">CADTH<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u2019s drug recommendation processes match up to these<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">requirements<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">? Let\u2019s\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">start with<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0accountability.\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">Over<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0three-quarters of\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">CADTH\u2019s\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">directors<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0are employed by or\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">closely<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0associated with federal, provincial or territorial governments<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">,<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0with six being directly responsible for drug plans<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">.\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">CA<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">DTH\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">is\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u201c<\/span><\/span><a class=\"Hyperlink SCXW120596061\" href=\"https:\/\/www.cadth.ca\/media\/cdr\/cdr-pdf\/cdr_myths_facts_e.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"TextRun Underlined SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">owned<\/span><\/span><\/a><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0by<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">,<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0and reports directly to<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u201d<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">federal,\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">provincial and territorial\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">d<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">eputy\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">m<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">inisters of\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">h<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">ealth<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">. H<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">ealth\u00a0<\/span><span class=\"ContextualSpellingAndGrammarError SCXW120596061\">ministries<\/span><span class=\"NormalTextRun SCXW120596061\">\u00a0provide 85<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0percent<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0of CADTH\u2019s annual operating budget of\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">over<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0$<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">30<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0million<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">.\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">CADTH is not independent<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">, as it claims<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">.\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">CADTH\u2019s\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">clear<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">accountability<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">is\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">to the governments<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">that own and control it<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0and for which\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">it\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">is producing recommendations<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">.\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">CADTH should also be accountable to patients, especially those\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">with unmet needs\u00a0<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">who<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">se health depends on<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0access to new<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">,<\/span><\/span><span class=\"TextRun SCXW120596061\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW120596061\">\u00a0innovative drugs.<\/span><\/span><\/p>\n<p>CADTH has\u00a0an\u00a0expert committee\u00a0to review\u00a0cancer drugs and\u00a0another to review\u00a0all other medications.\u00a0Meetings of these committees\u00a0are not\u00a0transparent. They\u00a0are not\u00a0open to patients, pharmaceutical manufacturers, the public or the media,\u00a0and\u00a0their\u00a0proceedings are\u00a0not publicly available.\u00a0Patient groups and individuals\u00a0can\u00a0submit written comments but are not allowed to comment on draft reports\u00a0(other than\u00a0reports on\u00a0cancer drugs),\u00a0although drug manufacturers can.<span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p>Participation\u00a0of\u00a0everyone\u00a0involved in decision-making processes\u00a0is important\u00a0if these\u00a0processes are to be credible and citizens\u00a0are not to feel\u00a0excluded.\u00a0The cancer drug\u00a0committee\u00a0includes\u00a0three patient representatives,\u00a0but\u00a0the other\u00a0committee\u00a0has none.\u00a0Patients are denied\u00a0genuine\u00a0participation in CADTH\u2019s drug recommendation processes, except with respect to cancer drugs.<span data-ccp-props=\"{}\">\u00a0<\/span>The absence of real accountability, transparency and participation in\u00a0CADTH\u2019s\u00a0drug recommendation processes means that opportunities do not exist for\u00a0everyone\u00a0involved to improve or maintain their well-being\u00a0or for reaching\u00a0true consensus.\u00a0Accountability and transparency are fundamental principles of good governance,\u00a0and\u00a0all\u00a0participants,\u00a0particularly\u00a0patients,\u00a0should\u00a0have an opportunity to improve their well-being by\u00a0being engaged\u00a0throughout the process and having a voice in decision-making.\u00a0<span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p>The principles of good governance should be incorporated into reimbursement recommendation processes\u00a0but aren\u2019t,\u00a0because\u00a0CADTH has become\u00a0a willing partner\u00a0of federal, provincial and territorial governments\u2019\u00a0initiatives\u00a0to\u00a0contain\u00a0new drug costs.\u00a0This\u00a0was plainly demonstrated in a\u00a0<a href=\"https:\/\/ojrd.biomedcentral.com\/track\/pdf\/10.1186\/s13023-017-0611-7?site=ojrd.biomedcentral.com\">recent analysis<\/a>\u00a0of CADTH\u2019s recommendations for medications\u00a0for rare disorders. The positive recommendation rate for\u00a0rare disorder\u00a0drugs\u00a0with\u00a0an estimated annual cost of more than $55,000 was only 26\u00a0percent, whereas the rate for\u00a0those\u00a0costing less than $55,000 was 83\u00a0percent.<span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-ccp-props=\"{}\"><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">The<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">current\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">federal government was elected\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">in 2015\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">on a platform of openness,\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">accountability,\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">transparency and fairness<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">.<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">The external reviewers of the pan-Canadian health organizations\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">should<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">\u00a0recommend that f<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">ederal, provincial and territorial governments apply these\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">democratic\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">values\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">to drug<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">\u00a0reimbursement assessments<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">to provide<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">Canadian<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">s\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">with\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">a<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">n<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">ational<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">organization<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">for evaluating drugs for\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">public drug plan coverage\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">that\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">fully\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">embraces\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">the princ<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">iples of good governance<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">\u2015 one\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">that is\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">pub<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">licly accountable<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">, transparent and fair and\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">includes\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">all\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">participants<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">throughout\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">the\u00a0<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">process<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">.<\/span><\/span><span class=\"TextRun SCXW74413371\" lang=\"EN-CA\" xml_lang=\"EN-CA\"><span class=\"NormalTextRun SCXW74413371\">\u00a0<\/span><\/span><span class=\"EOP SCXW74413371\" data-ccp-props=\"{}\">\u00a0<\/span><\/span><\/p>\n<p><span class=\"image-caption\">Photo: Shutterstock, by\u00a0LaryLitvin.<\/span><\/p>\n<hr \/>\n<p><span data-ccp-props=\"{}\">\u00a0<em>Do you have something to say about the article you just read? Be part of the\u00a0<\/em>Policy Options<em>\u00a0discussion, and send in your own submission.\u00a0Here is a\u00a0<\/em><a href=\"https:\/\/policyoptions.irpp.org\/fr\/article-submission\/\"><em>link<\/em><\/a><em>\u00a0on how to do it.\u00a0<\/em><em>|\u00a0Souhaitez-vous r\u00e9agir \u00e0 cet article ?\u00a0<\/em><em>Joignez-vous aux d\u00e9bats d\u2019<\/em>Options politiques\u00a0<em>et soumettez-nous votre texte en suivant ces\u00a0<\/em><a href=\"https:\/\/policyoptions.irpp.org\/fr\/article-submission\/\"><em>directives<\/em><\/a><em>.<\/em><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The federal Minister of Health has initiated an external\u00a0review\u00a0of eight pan-Canadian health organizations. One of these is\u00a0the\u00a0Canadian Agency for Drugs and Technologies in Health (CADTH), which evaluates\u00a0and recommends\u00a0new drugs for insurance coverage within all federal, provincial and territorial public drug plans, except those in Quebec. CADTH\u00a0describes\u00a0itself as \u201can independent, not-for-profit organization responsible for providing Canada\u2019s [&hellip;]<\/p>\n","protected":false},"featured_media":256064,"template":"","meta":{"_acf_changed":false,"content-type":"","ep_exclude_from_search":false,"apple_news_api_created_at":"2025-10-08T01:56:43Z","apple_news_api_id":"0a08988c-6bb5-42a0-b981-69c85dcbf5f9","apple_news_api_modified_at":"2025-10-08T01:56:43Z","apple_news_api_revision":"AAAAAAAAAAD\/\/\/\/\/\/\/\/\/\/w==","apple_news_api_share_url":"https:\/\/apple.news\/ACgiYjGu1QqC5gWnIXcv1-Q","apple_news_cover_media_provider":"image","apple_news_coverimage":0,"apple_news_coverimage_caption":"","apple_news_cover_video_id":0,"apple_news_cover_video_url":"","apple_news_cover_embedwebvideo_url":"","apple_news_is_hidden":"","apple_news_is_paid":"","apple_news_is_preview":"","apple_news_is_sponsored":"","apple_news_maturity_rating":"","apple_news_metadata":"\"\"","apple_news_pullquote":"","apple_news_pullquote_position":"","apple_news_slug":"","apple_news_sections":[],"apple_news_suppress_video_url":false,"apple_news_use_image_component":false},"categories":[9372,9377],"tags":[8666],"article-status":[],"irpp-category":[4317,4286],"section":[],"irpp-tag":[],"class_list":["post-265866","issues","type-issues","status-publish","has-post-thumbnail","hentry","category-recent-stories-fr","category-sante","tag-pharmacare-fr","irpp-category-assurance-maladie","irpp-category-sante"],"acf":[],"apple_news_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Good governance and decision-making on drug coverage<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Good governance and decision-making on drug coverage\" \/>\n<meta property=\"og:description\" content=\"The federal Minister of Health has initiated an external\u00a0review\u00a0of eight pan-Canadian health organizations. One of these is\u00a0the\u00a0Canadian Agency for Drugs and Technologies in Health (CADTH), which evaluates\u00a0and recommends\u00a0new drugs for insurance coverage within all federal, provincial and territorial public drug plans, except those in Quebec. CADTH\u00a0describes\u00a0itself as \u201can independent, not-for-profit organization responsible for providing Canada\u2019s [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/\" \/>\n<meta property=\"og:site_name\" content=\"Policy Options\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IRPP.org\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-08T01:56:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/policyoptions.irpp.org\/wp-content\/uploads\/2025\/08\/Final-option-3-rawson-money-no-us.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@irpp\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/\",\"url\":\"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/\",\"name\":\"Good governance and decision-making on drug coverage\",\"isPartOf\":{\"@id\":\"https:\/\/policyoptions.irpp.org\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/policyoptions.irpp.org\/wp-content\/uploads\/2025\/08\/Final-option-3-rawson-money-no-us.jpg\",\"datePublished\":\"2018-01-22T16:30:22+00:00\",\"dateModified\":\"2025-10-08T01:56:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/#primaryimage\",\"url\":\"https:\/\/policyoptions.irpp.org\/wp-content\/uploads\/2025\/08\/Final-option-3-rawson-money-no-us.jpg\",\"contentUrl\":\"https:\/\/policyoptions.irpp.org\/wp-content\/uploads\/2025\/08\/Final-option-3-rawson-money-no-us.jpg\",\"width\":2000,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/policyoptions.irpp.org\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Good governance and decision-making on drug coverage\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/policyoptions.irpp.org\/fr\/#website\",\"url\":\"https:\/\/policyoptions.irpp.org\/fr\/\",\"name\":\"Policy Options\",\"description\":\"Institute for Research on Public Policy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/policyoptions.irpp.org\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Good governance and decision-making on drug coverage","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/","og_locale":"fr_FR","og_type":"article","og_title":"Good governance and decision-making on drug coverage","og_description":"The federal Minister of Health has initiated an external\u00a0review\u00a0of eight pan-Canadian health organizations. One of these is\u00a0the\u00a0Canadian Agency for Drugs and Technologies in Health (CADTH), which evaluates\u00a0and recommends\u00a0new drugs for insurance coverage within all federal, provincial and territorial public drug plans, except those in Quebec. CADTH\u00a0describes\u00a0itself as \u201can independent, not-for-profit organization responsible for providing Canada\u2019s [&hellip;]","og_url":"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/","og_site_name":"Policy Options","article_publisher":"https:\/\/www.facebook.com\/IRPP.org","article_modified_time":"2025-10-08T01:56:41+00:00","og_image":[{"width":2000,"height":700,"url":"https:\/\/policyoptions.irpp.org\/wp-content\/uploads\/2025\/08\/Final-option-3-rawson-money-no-us.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@irpp","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/","url":"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/","name":"Good governance and decision-making on drug coverage","isPartOf":{"@id":"https:\/\/policyoptions.irpp.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/#primaryimage"},"image":{"@id":"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/#primaryimage"},"thumbnailUrl":"https:\/\/policyoptions.irpp.org\/wp-content\/uploads\/2025\/08\/Final-option-3-rawson-money-no-us.jpg","datePublished":"2018-01-22T16:30:22+00:00","dateModified":"2025-10-08T01:56:41+00:00","breadcrumb":{"@id":"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/#primaryimage","url":"https:\/\/policyoptions.irpp.org\/wp-content\/uploads\/2025\/08\/Final-option-3-rawson-money-no-us.jpg","contentUrl":"https:\/\/policyoptions.irpp.org\/wp-content\/uploads\/2025\/08\/Final-option-3-rawson-money-no-us.jpg","width":2000,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/policyoptions.irpp.org\/fr\/"},{"@type":"ListItem","position":2,"name":"Good governance and decision-making on drug coverage"}]},{"@type":"WebSite","@id":"https:\/\/policyoptions.irpp.org\/fr\/#website","url":"https:\/\/policyoptions.irpp.org\/fr\/","name":"Policy Options","description":"Institute for Research on Public Policy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/policyoptions.irpp.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/policyoptions.irpp.org\/fr\/wp-json\/wp\/v2\/issues\/265866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/policyoptions.irpp.org\/fr\/wp-json\/wp\/v2\/issues"}],"about":[{"href":"https:\/\/policyoptions.irpp.org\/fr\/wp-json\/wp\/v2\/types\/issues"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/policyoptions.irpp.org\/fr\/wp-json\/wp\/v2\/media\/256064"}],"wp:attachment":[{"href":"https:\/\/policyoptions.irpp.org\/fr\/wp-json\/wp\/v2\/media?parent=265866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/policyoptions.irpp.org\/fr\/wp-json\/wp\/v2\/categories?post=265866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/policyoptions.irpp.org\/fr\/wp-json\/wp\/v2\/tags?post=265866"},{"taxonomy":"article-status","embeddable":true,"href":"https:\/\/policyoptions.irpp.org\/fr\/wp-json\/wp\/v2\/article-status?post=265866"},{"taxonomy":"irpp-category","embeddable":true,"href":"https:\/\/policyoptions.irpp.org\/fr\/wp-json\/wp\/v2\/irpp-category?post=265866"},{"taxonomy":"section","embeddable":true,"href":"https:\/\/policyoptions.irpp.org\/fr\/wp-json\/wp\/v2\/section?post=265866"},{"taxonomy":"irpp-tag","embeddable":true,"href":"https:\/\/policyoptions.irpp.org\/fr\/wp-json\/wp\/v2\/irpp-tag?post=265866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}